Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy

S Raj, S Khurana, R Choudhari, KK Kesari… - Seminars in cancer …, 2021 - Elsevier
Nanotechnology has been the latest approach for diagnosis and treatment for cancer, which
opens up a new alternative therapeutic drug delivery option to treat disease. Nanoparticles …

The challenge of genetic variants of uncertain clinical significance: a narrative review

W Burke, E Parens, WK Chung, SM Berger… - Annals of internal …, 2022 - acpjournals.org
Genomic tests expand diagnostic and screening opportunities but also identify genetic
variants of uncertain clinical significance (VUSs). Only a minority of VUSs are likely to prove …

4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)

F Cardoso, E Senkus, A Costa… - Annals of …, 2018 - annalsofoncology.org
Advanced Breast Cancer (ABC) comprises both locally advanced breast cancer (LABC) and
metastatic breast cancer (MBC)[1]. Although treatable, MBC remains virtually an incurable …

Microbiome—microbial metabolome—cancer cell interactions in breast cancer—familiar, but unexplored

E Mikó, T Kovács, É Sebő, J Tóth, T Csonka, G Ujlaki… - Cells, 2019 - mdpi.com
Breast cancer is a leading cause of death among women worldwide. Dysbiosis, an aberrant
composition of the microbiome, characterizes breast cancer. In this review we discuss the …

Advances in quantum dot-based biosensors for DNA-modifying enzymes assay

Q Zhang, X Zhang, F Ma, C Zhang - Coordination Chemistry Reviews, 2022 - Elsevier
DNA-modifying enzymes participate in various genetic functions (eg, DNA replication,
repairing, and recombination) through alternating certain DNA sequence, and the …

Breast cancer, screening and diagnostic tools: All you need to know

D Barba, A León-Sosa, P Lugo, D Suquillo… - Critical reviews in …, 2021 - Elsevier
Breast cancer is one of the most frequent malignancies among women worldwide. Methods
for screening and diagnosis allow health care professionals to provide personalized …

The burden and trends of breast cancer from 1990 to 2017 at the global, regional, and national levels: results from the global burden of disease study 2017

P Ji, Y Gong, ML Jin, X Hu, GH Di, ZM Shao - Frontiers in oncology, 2020 - frontiersin.org
Background: Data on burden and changing trends of breast cancer are of value for
policymaking. We aimed to determine the pattern of breast cancer incidence, mortality, and …

Detection of germline mutations in a cohort of 139 patients with bilateral breast cancer by multi-gene panel testing: impact of pathogenic variants in other genes …

D Fanale, L Incorvaia, C Filorizzo, M Bono, A Fiorino… - Cancers, 2020 - mdpi.com
Simple Summary Many bilateral breast cancer patients with increased hereditary
susceptibility to breast cancer result negative for BRCA1 or BRCA2 pathogenic variants and …

Fe3O4 nanoparticles coated with carboxymethyl chitosan containing curcumin in combination with hyperthermia induced apoptosis in breast cancer cells

N Pazouki, S Irani, N Olov, SM Atyabi… - Progress in …, 2022 - Springer
Many studies have demonstrated that curcumin has potential anticancer properties. This
research aims to study the effect of iron (II, III) oxide (Fe3O4) nanoparticles coated with …

Incidence and survival among young women with stage I–III breast cancer: SEER 2000–2015

A Thomas, A Rhoads, E Pinkerton… - JNCI cancer …, 2019 - academic.oup.com
Background Although recent findings suggest that de novo stage IV breast cancer is
increasing in premenopausal women in the United States, contemporary incidence and …